Hepion Pharmaceuticals (HEPA) Announces Passing of Key Safety Milestone in Phase 2b ‘ASCEND-NASH’ Trial...
Completion of Enrollment Remains on Track for Q1, 2024
"While we recently had fireworks, we could be looking at real fireworks in the coming year....
Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within Minutes, With no...
Photo MAPS Founder Rick Doblin visits Psycheceutical's Chief Visionary Officer Mike 'Zappy' Zapolin, CEO Chad Harman at the company's lab and tests NeuroDirect™ Ketamine....
Psycheceutical Bioscience (BWVI) Secures Funding for Clinical Trials
Psycheceutical Secures Funding for Clinical Trials of NeuroDirect™ Ketamine Topical to Treat PTSD.
Company raises $1.3M USD convertible note from Cantheon Capital for in-human trials...
Hepion Pharma (HEPA). Artificial Intelligence (AI) to Speed Drug Development.
Hepion Pharmaceuticals (HEPA) to Highlight AI-POWR™ at the 2023 CSPS Annual Symposium: The Next Frontiers in Pharmaceutical Sciences
https://youtu.be/CE7es4l1avM
EDISON, N.J., (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals,...
Pressure Bioscience (PBIO) Meets Ohio State University. Pressure Testing on Food and Beverages.
OHIO STATE INSTALLS, COMMISSIONS NEW PILOT-SCALE ULTRA-SHEAR TECHNOLOGY EQUIPMENT FOR LIQUID FOODS AND BEVERAGES PROCESSING
Past News From Ohio State Worth Reviewing.
June 2022: Study Completed...
Adding Pressure BioSciences (PBIO) $0.80 to Watch List.
Long Time Coming, Pressure Bio Reaches Turning Point. Science Finally Meets Revenues.
Photo Ric Schumacher CEO
SHORT TERM CHART
LIVE QUOTE
When we say "finally" meets revenues, that's...
CEO Interview: Ric Schumacher Pressure Bioscience (PBIO).
https://youtu.be/a8d1bawmMQk
RELATED: Adding Pressure BioSciences (PBIO) $0.80 to Watch List
Pressure BioSciences, Inc. (OTCQB:PBIO) is a global leader in providing innovative, broadly enabling, high pressure-based solutions...
Pressure BioSciences (PBIO) Receives $1.5M Contract for UltraShear Nanoemulsified CBD.
CBD Supply MD, a Leading Maryland-Based CBD Retailer, to Introduce PBIO's UltraShear Processed, Best-in-Class Nanoemulsified CBD Products Across the Multi-State Mid-Atlantic Region
SOUTH EASTON, MA...
Asia-Pacific: A Region of Stability Amidst Economic Uncertainty
Contrary to the Western markets, there is a growing consensus that the Asia Pacific is emerging as a relatively safe harbour in these turbulent...
Hepion (HEPA) Back in the Spotlight, Gains 230% in May.
Hepion (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and Multiple NASH Biomarkers.
Definitely NOT for traders or...
Latest article
Cardiol Therapeutics (CRDL) May 2025 Presentation.
Click here to open.
RELATED: Cardiol’s (CRDL) Game-Changing Solution for Heart Inflammation? | David Elsley CEO – Video Interview
Nice Bounce on Alkaline Water (WTER) up 81%.
Well now that ain't bad, up 81%!
Our outlook on The Alkaline Water Company, our "comeback of the decade" story, is "let's see what...
Zomedica Corp (ZOMDF) $0.05
Company Overview
Background
Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is headquartered in Ann Arbor, Michigan. Initially listed on the TSX Venture...
